Subscribe

Michael R. Page, PharmD, RPh

Articles by Michael R. Page, PharmD, RPh

Trial Initiated to Measure Efficacy of T-Cell Therapy in Secondary Progressive MS

ByMichael R. Page, PharmD, RPh

June 13th 2014

Opexa Therapeutics is initiating a phase IIb trial of a novel therapy that targets T-cells in patients with secondary progressive multiple sclerosis.

Latest Updated Articles

Trial Initiated to Measure Efficacy of T-Cell Therapy in Secondary Progressive MS
June 13th 2014